Zobrazeno 1 - 5 of 5 pro vyhledávání: '"Thomas Uldrick"'
1
Akademický článek
Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome.
Autor: Nazzarena Labo, Wendell Miley, Vickie Marshall, William Gillette, Dominic Esposito, Matthew Bess, Alexandra Turano, Thomas Uldrick, Mark N Polizzotto, Kathleen M Wyvill, Rachel Bagni, Robert Yarchoan, Denise Whitby
Publikováno v: PLoS Pathogens, Vol 10, Iss 3, p e1004046 (2014)
The Kaposi sarcoma associated herpesvirus (KSHV) genome encodes more than 85 open reading frames (ORFs). Serological evaluation of KSHV infection now generally relies on reactivity to just one latent and/or one lytic protein (commonly ORF73 and K8.1)
Externí odkaz: https://doaj.org/article/a2baf30b576441df8c29053bc13572ff
Zobrazit plný text záznamu
3
Abstract 5611: LAG-3 PET imaging in patients with cancer before immune checkpoint inhibitor therapy
Autor: Pim P. van de Donk, Lotte M. Smit, Joyce van Sluis, Wim Timens, Adrienne H. Brouwers, Marjolijn N. Lub- de Hooge, Sjoerd G. Elias, Jourik A. Gietema, Claudia A. van Winkel, JuAn Wang, Jason Giurleo, Thomas Uldrick, Hung Kam Cheung, Hilde Jalving, Sjoukje F. Oosting, Daan G. Knapen, Derk-Jan A. de Groot, Elisabeth G. de Vries
Publikováno v: Cancer Research. 83:5611-5611
Background Immune checkpoint inhibitors (ICIs) can induce durable responses in multiple different tumor types. Lymphocyte activation gene-3 (LAG-3) is one of the immune checkpoints for which therapeutic antibodies are being developed. PET imaging wit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::850640f5c1c72bc2b211c4d5efa4a87a
https://doi.org/10.1158/1538-7445.am2023-5611
Zobrazit plný text záznamu
4
Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal
Autor: Deborah Citrin, Luca Valle, Kevin Camphausen, Theresa Cooley‑zgela, Deedee Smart, Michael Yao, James Mitchell, William Thompson, Irini Sereti, Thomas Uldrick
Publikováno v: Int J Oncol
The purpose of the present trial was to determine the feasibility of the daily topical application of the piperidine nitroxide, MTS-01, combined with chemoradiotherapy in the treatment of patients with anal carcinoma. The secondary study endpoints we
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a14e7f4851164030483adfb0c333764
https://doi.org/10.3892/ijo.2022.5358
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje